Your session is about to expire
← Back to Search
Pain and Hysteroscopy
N/A
Waitlist Available
Led By Jose Carugno, MD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1 (post-procedure)
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether telling patients what to expect during a medical procedure will make them more comfortable.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 1 (post-procedure)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1 (post-procedure)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Pain as measured by Visual Analog Scale (VAS)
Secondary study objectives
Number of participants in each pain category
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Objective Description GroupExperimental Treatment1 Intervention
Participants will be prompted using objective description language during the standard of care hysteroscopy.
Group II: Anticipated Discomfort GroupExperimental Treatment1 Intervention
Participants will be prompted using anticipated discomfort language during the standard of care hysteroscopy.
Find a Location
Who is running the clinical trial?
University of MiamiLead Sponsor
953 Previous Clinical Trials
428,751 Total Patients Enrolled
Jose Carugno, MDPrincipal InvestigatorUniversity of Miami
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Anticipated Discomfort Group
- Group 2: Objective Description Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.